Vivian Wang guides clients on all aspects of antitrust matters, especially through the antitrust merger review processes and in antitrust government investigations across a wide range of industries, including technology, life sciences, financial services, consumer goods and business services. She is also experienced in anti-corruption investigations and compliance counseling.
Prior to joining the firm, Vivian worked at the DC offices of prominent US law firms.
- Sanofi in its US$1.9 billion acquisition of Kadmon Holdings, Inc.
- Sanofi in its US$3.2 billion acquisition of Translate Bio
- Foley Trasimene Acquisition Corp. in its $7.3 billion merger with Alight Solutions LLC
- Sanofi in its US$1.45 billion acquisition of Kymab, Ltd.
- Foley Trasimene Acquisition Corp. II in its US$9 billion merger with Paysafe
- Black Knight in its US$1.8 billion acquisition of Optimal Blue
- Allergan plc in its US$63 billion sale to AbbVie Inc.
- A US investment holding company in its unsolicited offer to acquire a real estate data & analytics company
- Various private equity funds in the acquisitions in the pharmaceuticals, logistics and data & analytics sectors
- Various Chinese State-Owned-Enterprises in anti-corruption investigations and the design and implementation of compliance programs
Languages
- Mandarin Chinese
- English
Admissions
Bar Admissions
- New York
- District of Columbia
Education
- New York University School of Law, J.D.
- Georgetown University Law Center, LL.M.
- Peking University, LL.B.; B.A.
Honors & Awards
- Recognized by The Legal 500 Greater China (2024) in China, Antitrust and Competition: Foreign Firms
Professional Activities
Member
- American Bar Association, Antitrust Section
Related Practices